The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni
Open accessAbstract
BACKGROUND: The near exclusive use of praziquantel (PZQ) for treatment of human schistosomiasis has raised concerns about the possible emergence of drug-resistant schistosomes. METHODOLOGY/PRINCIPAL FINDINGS: We measured susceptibility to PZQ of isolates of Schistosoma mansoni obtained from patients from Kisumu, Kenya continuously exposed to infection as a consequence of their occupations as car washers or sand harvesters. We used a) an in vitro assay with miracidia, b) an in vivo assay targeting adult worms in mice and c) an in vitro assay targeting adult schistosomes perfused from mice. In the miracidia assay, in which miracidia from human patients were exposed to PZQ in vitro, reduced susceptibility was associated with previous treatment of the patient with PZQ. One isolate ("KCW") that was less susceptible to PZQ and had been derived from a patient who had never fully cured despite multiple treatments was studied further. In an in vivo assay of adult worms, the KCW isolate was significantly less susceptible to PZQ than two other isolates from natural infections in Kenya and two lab-reared strains of S. mansoni. The in vitro adult assay, based on measuring length changes of adults following exposure to and recovery from PZQ, confirmed that the KCW isolate was less susceptible to PZQ than the other isolates tested. A sub-isolate of KCW maintained separately and tested after three years was susceptible to PZQ, indicative that the trait of reduced sensitivity could be lost if selection was not maintained. CONCLUSIONS/SIGNIFICANCE: Isolates of S. mansoni from some patients in Kisumu have lower susceptibility to PZQ, including one from a patient who was never fully cured after repeated rounds of treatment administered over several years. As use of PZQ continues, continued selection for worms with diminished susceptibility is possible, and the probability of emergence of resistance will increase as large reservoirs of untreated worms diminish. The potential for rapid emergence of resistance should be an important consideration of treatment programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steinmann, P., Keiser, J., Bos, R., Tanner, M., & Utzinger, J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70521-7 · Cited by 2,156
van Wyk, J. A. (2001) · PubMed · Cited by 528
Ismail, M., Botros, S., Metwally, A., William, S., Farghally, A., Tao, L. F., Day, T. A., & Bennett, J. L. (1999) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.1999.60.932 · Cited by 495
How Much Human Helminthiasis Is There in the World?
Crompton, D. W. T. (1999) · The Journal of Parasitology · doi:10.2307/3285768 · Cited by 494
Fallon, P. G., & Doenhoff, M. J. (1994) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1994.51.83 · Cited by 483
Modes and Modulations of Antibiotic Resistance Gene Expression
Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., & Courvalin, P. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00015-06 · Cited by 427
Praziquantel, a new broad-spectrum antischistosomal agent
G�nnert, R., & Andrews, P. (1977) · Zeitschrift f�r Parasitenkunde · doi:10.1007/bf00389899 · Cited by 412
Pica‐Mattoccia, L., & Cioli, D. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2003.12.003 · Cited by 364
Cioli, D., & Pica-Mattoccia, L. (2003) · Parasitology Research · doi:10.1007/s00436-002-0751-z · Cited by 343
Ismail, M., Metwally, A., Farghaly, A., Bruce, J., Tao, L.-F., & Bennett, J. L. (1996) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.55.214 · Cited by 315
Drugs for the control of parasitic diseases: current status and development in schistosomiasis
Fenwick, A., Savioli, L., Engels, D., Robert Bergquist, N., & Todd, M. H. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.005 · Cited by 299
Schistosomiasis: challenges for control, treatment and drug resistance
Fenwick, A., & Webster, J. P. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000247591.13671.6a · Cited by 254
Pax, R., Bennett, J. L., & Fetterer, R. (1978) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00507974 · Cited by 234
Short Report: Diminished Susceptibility to Praziquantel in a Senegal Isolate of Schistosoma mansoni
Fallon, P. G., Sturrock, R. F., Capron, A., Niang, M., & Doenhoff, M. J. (1995) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1995.53.61 · Cited by 212
Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal
Danso-Appiah, A., & De Vlas, S. J. (2002) · Trends in Parasitology · doi:10.1016/s1471-4922(01)02209-7 · Cited by 197
Towards an understanding of the mechanism of action of praziquantel
Aragon, A. D., Imani-Shikhabadi, R., Blackburn, V. R., Cupit, P. M., Melman, S. D., Goronga, T., Webb, T., Loker, E. S., & Cunningham, C. (2008) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2008.11.007 · Cited by 156
Self-citationKaranja, D. M. S., Hightower, A. W., Colley, D. G., Mwinzi, P. N. M., Galil, K., Andove, J., & Secor, W. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09781-7 · Cited by 141
Self-citationALONSO, D., Muñóz, J., Gascón, J., Valls, M. E., & Corachan, M. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.74.342 · Cited by 140
Origin and diversification of the human parasite Schistosoma mansoni
Morgan, J. A. T., DeJong, R. J., Adeoye, G. O., Ansa, E. D. O., Barbosa, C. S., Brémond, P., Cesari, I. M., Charbonnel, N., Corrêa, L. R., Coulibaly, G., et al. (2005) · Molecular Ecology · doi:10.1111/j.1365-294x.2005.02709.x · Cited by 133
Self-citationCurrent status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt
Botros, S. S., Sayed, H. A. E., Amer, N. M., El-Ghannam, M., Bennett, J. L., & Day, T. A. (2005) · International Journal for Parasitology · doi:10.1016/j.ijpara.2005.02.005 · Cited by 128
Cioli, D., Botros, S. S., Wheatcroft-Francklow, K., Mbaye, A. I., Southgate, V. R., Tchuenté, L.-A. T., Pica‐Mattoccia, L., Troiani, A. R., el-Din, S. H. S., Sabra, A.-N. A., et al. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2004.05.001 · Cited by 126
Satayathum, S., Muchiri, E. M., Ouma, J. H., Whalen, C. C., & King, C. H. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.75.83 · Cited by 115
Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya
King, C. H., Muchiri, E. M., & Ouma, J. H. (2000) · Emerging infectious diseases · doi:10.3201/eid0606.000606 · Cited by 114
Schistosomiasis control: keep taking the tablets
Hagan, P., Appleton, C. C., Coles, G. C., Kusel, J. R., & Tchuem-Tchuenté, L. A. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.11.010 · Cited by 105
In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel
Liang, Y.-S., Coles, G. C., Doenhoff, M. J., et al. (2001) · International Journal for Parasitology · doi:10.1016/s0020-7519(01)00246-6 · Cited by 100
Karanja, D. M. S., Boyer, A. E., Strand, M., Colley, D. G., Nahlen, B. L., Ouma, J. H., & Secor, W. E. (1998) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1998.59.307 · Cited by 90
Self-citationMagnussen, P. (2003) · Acta Tropica · doi:10.1016/s0001-706x(03)00045-7 · Cited by 74
Black, C. L., Steinauer, M. L., Mwinzi, P. N. M., Secor, W. E., Karanja, D. M. S., & Colley, D. G. (2009) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2009.02234.x · Cited by 70
Self-citationStrategies for managing today's infections
Carmeli, Y. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01957.x · Cited by 47
Recent initiatives and strategies to developing new drugs for tropical parasitic diseases
Caffrey, C. R., & Steverding, D. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.2.173 · Cited by 44
Genetic structure of Schistosoma mansoni in western Kenya: The effects of geography and host sharing
Steinauer, M. L., Hanelt, B., Agola, L. E., Mkoji, G. M., & Loker, E. S. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.04.010 · Cited by 41
Self-citationBrindley, P. J., Heath, S. C., Waters, A. P., McCutchan, T. F., & Sher, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7754 · Cited by 29
Cited by
UTZINGER, J., RASO, G., BROOKER, S., DE SAVIGNY, D., TANNER, M., ØRNBJERG, N., SINGER, B. H., & N'GORAN, E. K. (2009) · Parasitology · doi:10.1017/s0031182009991600 · Cited by 418
Susceptibility or resistance of praziquantel in human schistosomiasis: a review
Wang, W., Wang, L., & Liang, Y.-S. (2012) · Parasitology Research · doi:10.1007/s00436-012-3151-z · Cited by 384
Whole genome analysis of a schistosomiasis-transmitting freshwater snail
Adema, C. M., Hillier, L. W., Jones, C. S., Loker, E. S., Knight, M., Minx, P., Oliveira, G., Raghavan, N., Shedlock, A., do Amaral, L. R., et al. (2017) · Nature Communications · doi:10.1038/ncomms15451 · Cited by 292
Self-citationThe anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand
Chan, J. D., Cupit, P. M., Gunaratne, G. S., McCorvy, J. D., Yang, Y., Stoltz, K., Webb, T. R., Dosa, P. I., Roth, B. L., Abagyan, R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02084-0 · Cited by 69
Self-citationSimoben, C., Robaa, D., Chakrabarti, A., Schmidtkunz, K., Marek, M., Lancelot, J., Kannan, S., Melesina, J., Shaik, T., Pierce, R., et al. (2018) · Molecules · doi:10.3390/molecules23030566 · Cited by 44
Metadata
- Authors
- Melman, S. D., Steinauer, M. L., Cunningham, C., Kubatko, L. S., Mwangi, I. N., Wynn, N. B., Mutuku, M. W., Karanja, D. M. S., Colley, D. G., Black, C. L., Secor, W. E., Mkoji, G. M., & Loker, E. S.
- Venue
- PLoS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-08-18
- Volume
- 3
- Issue
- 8
- Pages
- e504
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- OpenAlex
- W2066835202
- Cited by
- 445
- References
- 32
- FWCI
- 17.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.